Skip to main content
Top
Published in: International Urology and Nephrology 9/2017

01-09-2017 | Urology - Original Paper

From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy

Authors: R. Mager, M. P. Brandt, H. Borgmann, K. M. Gust, A. Haferkamp, M. Kurosch

Published in: International Urology and Nephrology | Issue 9/2017

Login to get access

Abstract

Purpose

To investigate the learning curve of a novice in MRI/TRUS software fusion biopsy and to compare his results with the expert standard at our institution.

Methods

Overall 126 MRI/TRUS fusion-guided transrectal biopsies were performed using an electromagnetic tracking ultrasonography platform. The learning progress of the novice was evaluated comparing his initial 42 procedures (group A) with his following 42 (group B). The institution’s expert standard (group C), which was compared to the novice’s groups, was defined by the expert’s experience of 42 MRI/TRUS fusion biopsies. Primary learning curve parameters were targeted biopsy detection quotient and biopsy time.

Results

Overall detection of prostate cancer was 64% (27/42), 62% (26/42) and 62% (26/42) in groups A, B and C, respectively. The median target biopsy detection quotient significantly increased (p = 0.04) in group B (0.75, interquartile range (IQR) 0.25–1.0) compared to group A. (0.33, IQR 0.2–0.5). Group C revealed a median detection quotient of 0.5 (IQR 0.25–0.76) that did not differ significantly from the novice’s groups (p = 0.2). Median biopsy time was significantly higher in group A (45 min, IQR 33–50 min) compared to groups B (25 min, IQR 23–29 min) and C (24 min, IQR 16–46 min) (p < 0.01).

Conclusions

The present study revealed the individual learning curve of a novice in MRI/TRUS fusion biopsy and demonstrated significant learning progress regarding targeted biopsy detection quotient and biopsy time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, Henry A, Joniau S, Lam T, Mason M, Matveev V, van der Poel H, van der Kwast T, Rouviere O, Wiegel T (2016) The European Association of Urology (EAU) Prostate Cancer (PCa) Guidelines. https://uroweb.org/guideline/prostate-cancer/#5. Accessed 25 April 2016 Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, Henry A, Joniau S, Lam T, Mason M, Matveev V, van der Poel H, van der Kwast T, Rouviere O, Wiegel T (2016) The European Association of Urology (EAU) Prostate Cancer (PCa) Guidelines. https://​uroweb.​org/​guideline/​prostate-cancer/​#5. Accessed 25 April 2016
2.
go back to reference Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Futterer JJ, Barentsz JO (2010) Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 183(2):520–527. doi:10.1016/j.juro.2009.10.022 CrossRefPubMed Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Futterer JJ, Barentsz JO (2010) Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 183(2):520–527. doi:10.​1016/​j.​juro.​2009.​10.​022 CrossRefPubMed
3.
go back to reference Walton Diaz A, Shakir NA, George AK, Rais-Bahrami S, Turkbey B, Rothwax JT, Stamatakis L, Hong CW, Siddiqui MM, Okoro C, Raskolnikov D, Su D, Shih J, Han H, Parnes HL, Merino MJ, Simon RM, Wood BJ, Choyke PL, Pinto PA (2015) Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. Urol Oncol 33(5):202.e1–202.e7. doi:10.1016/j.urolonc.2015.01.023 CrossRef Walton Diaz A, Shakir NA, George AK, Rais-Bahrami S, Turkbey B, Rothwax JT, Stamatakis L, Hong CW, Siddiqui MM, Okoro C, Raskolnikov D, Su D, Shih J, Han H, Parnes HL, Merino MJ, Simon RM, Wood BJ, Choyke PL, Pinto PA (2015) Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. Urol Oncol 33(5):202.e1–202.e7. doi:10.​1016/​j.​urolonc.​2015.​01.​023 CrossRef
4.
go back to reference Da Rosa MR, Milot L, Sugar L, Vesprini D, Chung H, Loblaw A, Pond GR, Klotz L, Haider MA (2015) A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging 41(1):220–225. doi:10.1002/jmri.24710 CrossRefPubMed Da Rosa MR, Milot L, Sugar L, Vesprini D, Chung H, Loblaw A, Pond GR, Klotz L, Haider MA (2015) A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging 41(1):220–225. doi:10.​1002/​jmri.​24710 CrossRefPubMed
5.
go back to reference Marliere F, Puech P, Benkirane A, Villers A, Lemaitre L, Leroy X, Betrouni N, Ouzzane A (2014) The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. World J Urol 32(4):951–958. doi:10.1007/s00345-014-1314-5 CrossRefPubMed Marliere F, Puech P, Benkirane A, Villers A, Lemaitre L, Leroy X, Betrouni N, Ouzzane A (2014) The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. World J Urol 32(4):951–958. doi:10.​1007/​s00345-014-1314-5 CrossRefPubMed
6.
go back to reference Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H (2012) Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol 188(5):1732–1738. doi:10.1016/j.juro.2012.07.024 CrossRefPubMed Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H (2012) Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol 188(5):1732–1738. doi:10.​1016/​j.​juro.​2012.​07.​024 CrossRefPubMed
7.
go back to reference Ghai S, Louis AS, Van Vliet M, Lindner U, Haider MA, Hlasny E, Spensieri P, Van Der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J (2015) Real-time MRI-guided focused ultrasound for focal therapy of locally confined low-risk prostate cancer: feasibility and preliminary outcomes. Am J Roentgenol 205(2):W177–W184. doi:10.2214/AJR.14.13098 CrossRef Ghai S, Louis AS, Van Vliet M, Lindner U, Haider MA, Hlasny E, Spensieri P, Van Der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J (2015) Real-time MRI-guided focused ultrasound for focal therapy of locally confined low-risk prostate cancer: feasibility and preliminary outcomes. Am J Roentgenol 205(2):W177–W184. doi:10.​2214/​AJR.​14.​13098 CrossRef
8.
go back to reference Chin JL, Billia M, Relle J, Roethke MC, Popeneciu IV, Kuru TH, Hatiboglu G, Mueller-Wolf MB, Motsch J, Romagnoli C, Kassam Z, Harle CC, Hafron J, Nandalur KR, Chronik BA, Burtnyk M, Schlemmer HP, Pahernik S (2016) Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. doi:10.1016/j.eururo.2015.12.029 PubMed Chin JL, Billia M, Relle J, Roethke MC, Popeneciu IV, Kuru TH, Hatiboglu G, Mueller-Wolf MB, Motsch J, Romagnoli C, Kassam Z, Harle CC, Hafron J, Nandalur KR, Chronik BA, Burtnyk M, Schlemmer HP, Pahernik S (2016) Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. doi:10.​1016/​j.​eururo.​2015.​12.​029 PubMed
10.
go back to reference van den Bos W, de Bruin DM, van Randen A, Engelbrecht MR, Postema AW, Muller BG, Varkarakis IM, Skolarikos A, Savci-Heijink CD, Jurhill RR, Zondervan PJ, Laguna Pes MP, Wijkstra H, de Reijke TM, de la Rosette JJ (2016) MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I–II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol 26(7):2252–2260. doi:10.1007/s00330-015-4042-3 CrossRefPubMed van den Bos W, de Bruin DM, van Randen A, Engelbrecht MR, Postema AW, Muller BG, Varkarakis IM, Skolarikos A, Savci-Heijink CD, Jurhill RR, Zondervan PJ, Laguna Pes MP, Wijkstra H, de Reijke TM, de la Rosette JJ (2016) MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I–II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol 26(7):2252–2260. doi:10.​1007/​s00330-015-4042-3 CrossRefPubMed
11.
go back to reference Gaziev G, Wadhwa K, Barrett T, Koo BC, Gallagher FA, Serrao E, Frey J, Seidenader J, Carmona L, Warren A, Gnanapragasam V, Doble A, Kastner C (2016) Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. BJU Int 117(1):80–86. doi:10.1111/bju.12892 CrossRefPubMed Gaziev G, Wadhwa K, Barrett T, Koo BC, Gallagher FA, Serrao E, Frey J, Seidenader J, Carmona L, Warren A, Gnanapragasam V, Doble A, Kastner C (2016) Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. BJU Int 117(1):80–86. doi:10.​1111/​bju.​12892 CrossRefPubMed
12.
go back to reference Cash H, Gunzel K, Maxeiner A, Stephan C, Fischer T, Durmus T, Miller K, Asbach P, Haas M, Kempkensteffen C (2016) Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. BJU Int 118(1):35–43. doi:10.1111/bju.13327 CrossRefPubMed Cash H, Gunzel K, Maxeiner A, Stephan C, Fischer T, Durmus T, Miller K, Asbach P, Haas M, Kempkensteffen C (2016) Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. BJU Int 118(1):35–43. doi:10.​1111/​bju.​13327 CrossRefPubMed
13.
go back to reference Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Futterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64(4):544–552. doi:10.1016/j.eururo.2013.03.030 CrossRefPubMed Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Futterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64(4):544–552. doi:10.​1016/​j.​eururo.​2013.​03.​030 CrossRefPubMed
15.
go back to reference Cook JA, Ramsay CR, Fayers P (2004) Statistical evaluation of learning curve effects in surgical trials. Clin Trials 1(5):421–427CrossRefPubMed Cook JA, Ramsay CR, Fayers P (2004) Statistical evaluation of learning curve effects in surgical trials. Clin Trials 1(5):421–427CrossRefPubMed
16.
go back to reference Latchamsetty KC, Borden LS Jr, Porter CR, Lacrampe M, Vaughan M, Lin E, Conti N, Wright JL, Corman JM (2007) Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve? Can J Urol 14(1):3429–3434PubMed Latchamsetty KC, Borden LS Jr, Porter CR, Lacrampe M, Vaughan M, Lin E, Conti N, Wright JL, Corman JM (2007) Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve? Can J Urol 14(1):3429–3434PubMed
17.
go back to reference Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL (2014) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 39(6):1443–1448. doi:10.1002/jmri.24317 CrossRefPubMed Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL (2014) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 39(6):1443–1448. doi:10.​1002/​jmri.​24317 CrossRefPubMed
18.
go back to reference Costa DN, Yuan Q, Xi Y, Rofsky NM, Lenkinski RE, Lotan Y, Roehrborn CG, Francis F, Travalini D, Pedrosa I (2016) Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: a prospective, paired-patient study. Urol Oncol 34(6):255.e7–255.e13. doi:10.1016/j.urolonc.2016.02.009 CrossRef Costa DN, Yuan Q, Xi Y, Rofsky NM, Lenkinski RE, Lotan Y, Roehrborn CG, Francis F, Travalini D, Pedrosa I (2016) Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: a prospective, paired-patient study. Urol Oncol 34(6):255.e7–255.e13. doi:10.​1016/​j.​urolonc.​2016.​02.​009 CrossRef
19.
go back to reference Muthigi A, Sidana A, George AK, Kongnyuy M, Shakir N, Kadakia M, Maruf M, Frye TP, Mertan F, Su D, Merino MJ, Choyke PL, Turkbey B, Wood BJ, Pinto PA (2016) Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification. Int Urol Nephrol 48(9):1445–1452. doi:10.1007/s11255-016-1336-6 CrossRefPubMed Muthigi A, Sidana A, George AK, Kongnyuy M, Shakir N, Kadakia M, Maruf M, Frye TP, Mertan F, Su D, Merino MJ, Choyke PL, Turkbey B, Wood BJ, Pinto PA (2016) Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification. Int Urol Nephrol 48(9):1445–1452. doi:10.​1007/​s11255-016-1336-6 CrossRefPubMed
20.
go back to reference Zhang Q, Wang W, Zhang B, Shi J, Fu Y, Li D, Guo S, Zhang S, Huang H, Jiang X, Zhou W, Guo H (2017) Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China. Int Urol Nephrol 49(3):439–448. doi:10.1007/s11255-016-1484-8 CrossRefPubMed Zhang Q, Wang W, Zhang B, Shi J, Fu Y, Li D, Guo S, Zhang S, Huang H, Jiang X, Zhou W, Guo H (2017) Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China. Int Urol Nephrol 49(3):439–448. doi:10.​1007/​s11255-016-1484-8 CrossRefPubMed
21.
go back to reference Kuru TH, Roethke MC, Seidenader J, Simpfendorfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA (2013) Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190(4):1380–1386. doi:10.1016/j.juro.2013.04.043 CrossRefPubMed Kuru TH, Roethke MC, Seidenader J, Simpfendorfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA (2013) Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190(4):1380–1386. doi:10.​1016/​j.​juro.​2013.​04.​043 CrossRefPubMed
22.
go back to reference Barzell WE, Melamed MR, Cathcart P, Moore CM, Ahmed HU, Emberton M (2012) Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J Urol 188(3):762–767. doi:10.1016/j.juro.2012.04.107 CrossRefPubMed Barzell WE, Melamed MR, Cathcart P, Moore CM, Ahmed HU, Emberton M (2012) Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J Urol 188(3):762–767. doi:10.​1016/​j.​juro.​2012.​04.​107 CrossRefPubMed
23.
go back to reference Puech P, Rouviere O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mege-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 268(2):461–469. doi:10.1148/radiol.13121501 CrossRefPubMed Puech P, Rouviere O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mege-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 268(2):461–469. doi:10.​1148/​radiol.​13121501 CrossRefPubMed
24.
go back to reference Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397. doi:10.1001/jama.2014.17942 CrossRefPubMedPubMedCentral Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397. doi:10.​1001/​jama.​2014.​17942 CrossRefPubMedPubMedCentral
25.
go back to reference Delongchamps NB, Portalez D, Bruguiere E, Rouviere O, Malavaud B, Mozer P, Fiard G, Cornud F (2016) Are MRI-TRUS-guided targeted biopsies non-inferior to TRUS-guided systematic biopsies for the detection of prostate cancer in patients with a single suspicious focus on multiparametric prostate MRI? Results of a multicentric controlled trial. J Urol. doi:10.1016/j.juro.2016.04.003 Delongchamps NB, Portalez D, Bruguiere E, Rouviere O, Malavaud B, Mozer P, Fiard G, Cornud F (2016) Are MRI-TRUS-guided targeted biopsies non-inferior to TRUS-guided systematic biopsies for the detection of prostate cancer in patients with a single suspicious focus on multiparametric prostate MRI? Results of a multicentric controlled trial. J Urol. doi:10.​1016/​j.​juro.​2016.​04.​003
26.
go back to reference Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013) Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol 190(6):2020–2025. doi:10.1016/j.juro.2013.05.118 CrossRefPubMed Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013) Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol 190(6):2020–2025. doi:10.​1016/​j.​juro.​2013.​05.​118 CrossRefPubMed
27.
go back to reference Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64(5):713–719. doi:10.1016/j.eururo.2013.05.059 CrossRefPubMed Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64(5):713–719. doi:10.​1016/​j.​eururo.​2013.​05.​059 CrossRefPubMed
28.
go back to reference Radtke JP, Kuru TH, Boxler S, Alt CD, Popeneciu IV, Huettenbrink C, Klein T, Steinemann S, Bergstraesser C, Roethke M, Roth W, Schlemmer HP, Hohenfellner M, Hadaschik BA (2015) Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193(1):87–94. doi:10.1016/j.juro.2014.07.098 CrossRefPubMed Radtke JP, Kuru TH, Boxler S, Alt CD, Popeneciu IV, Huettenbrink C, Klein T, Steinemann S, Bergstraesser C, Roethke M, Roth W, Schlemmer HP, Hohenfellner M, Hadaschik BA (2015) Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193(1):87–94. doi:10.​1016/​j.​juro.​2014.​07.​098 CrossRefPubMed
29.
go back to reference Kuru TH, Roethke MC, Rieker P, Roth W, Fenchel M, Hohenfellner M, Schlemmer HP, Hadaschik BA (2013) Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate. BJU Int 112(8):1080–1087. doi:10.1111/bju.12259 CrossRefPubMed Kuru TH, Roethke MC, Rieker P, Roth W, Fenchel M, Hohenfellner M, Schlemmer HP, Hadaschik BA (2013) Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate. BJU Int 112(8):1080–1087. doi:10.​1111/​bju.​12259 CrossRefPubMed
30.
Metadata
Title
From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy
Authors
R. Mager
M. P. Brandt
H. Borgmann
K. M. Gust
A. Haferkamp
M. Kurosch
Publication date
01-09-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1642-7

Other articles of this Issue 9/2017

International Urology and Nephrology 9/2017 Go to the issue